Last reviewed · How we verify

VZV vaccination

The HIV Netherlands Australia Thailand Research Collaboration · FDA-approved active Biologic ✓ Verified May 2026 Quality 5/100

VZV vaccination is a Biologic drug developed by The HIV Netherlands Australia Thailand Research Collaboration. It is currently FDA-approved.

The Varicella (VZV) vaccine is a biological vaccine that induces an immune response. It is used to prevent conditions such as Varicella, and is often administered in combination with other vaccines, including those for Haemophilus Influenzae Type b and Neisseria Meningitidis.

At a glance

Generic nameVZV vaccination
SponsorThe HIV Netherlands Australia Thailand Research Collaboration
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about VZV vaccination

What is VZV vaccination?

VZV vaccination is a Biologic drug developed by The HIV Netherlands Australia Thailand Research Collaboration.

Who makes VZV vaccination?

VZV vaccination is developed and marketed by The HIV Netherlands Australia Thailand Research Collaboration (see full The HIV Netherlands Australia Thailand Research Collaboration pipeline at /company/the-hiv-netherlands-australia-thailand-research-collaboration).

What development phase is VZV vaccination in?

VZV vaccination is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing